U.S. researchers were able to reprogram adult cells into embryonic-like stem cell lines that contain the mutation linked to sickle cell anemia within 12 to 14 days using four genes and SV40 large T antigen, a viral protein. "Having these new cell lines available might enable some bigger projects, like screening for potential drugs," one of the researchers said.

Related Summaries